@Article{Sanglodkar2018,
journal="Clinical and Experimental Hepatology",
issn="2392-1099",
volume="4",
number="1",
year="2018",
title="Hemospray for recurrent esophageal band ulcer bleeding",
abstract="Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray.",
author="Sanglodkar, Uday A.
and Jothimani, Dinesh
and Rela, Mohamed",
pages="46--48",
doi="10.5114/ceh.2018.73668",
url="http://dx.doi.org/10.5114/ceh.2018.73668"
}